PCMA Challenges D.C.'s PBM "Transparency" Provision In Federal Court
This article was originally published in The Pink Sheet Daily
Executive Summary
The PBM association's arguments against Title II of D.C.'s "AccessRx Act of 2004" mirror those made in a similar case in Maine. PCMA contends that the law, which requires PBMs to disclose financial arrangements with drug manufacturers, is unconstitutional and preempted by ERISA.